Trial Information
SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724